Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 335

1.

Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.

Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP.

J Am Coll Surg. 2014 Feb;218(2):206-17. doi: 10.1016/j.jamcollsurg.2013.10.009. Epub 2013 Oct 25.

PMID:
24315890
2.

Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.

Singer S, Antonescu CR, Riedel E, Brennan MF.

Ann Surg. 2003 Sep;238(3):358-70; discussion 370-1.

3.

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.

Toulmonde M, Bonvalot S, Méeus P, Stoeckle E, Riou O, Isambert N, Bompas E, Jafari M, Delcambre-Lair C, Saada E, Le Cesne A, Le Péchoux C, Blay JY, Piperno-Neumann S, Chevreau C, Bay JO, Brouste V, Terrier P, Ranchère-Vince D, Neuville A, Italiano A; French Sarcoma Group..

Ann Oncol. 2014 Mar;25(3):735-42. doi: 10.1093/annonc/mdt577.

4.

Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.

Park JO, Qin LX, Prete FP, Antonescu C, Brennan MF, Singer S.

Ann Surg. 2009 Dec;250(6):977-82.

5.

The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.

Mussi C, Collini P, Miceli R, Barisella M, Mariani L, Fiore M, Casali PG, Gronchi A.

Cancer. 2008 Oct 1;113(7):1657-65. doi: 10.1002/cncr.23774.

6.

Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.

Tseng W, Martinez SR, Tamurian RM, Borys D, Canter RJ.

J Surg Res. 2012 Jan;172(1):123-30. doi: 10.1016/j.jss.2010.07.056. Epub 2010 Sep 16.

PMID:
20869082
7.

Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.

Garcia-Ortega DY, Villa-Zepeda O, Martinez-Said H, Cuellar-Hübbe M, Luna-Ortiz K.

Int J Surg. 2016 Aug;32:45-9. doi: 10.1016/j.ijsu.2016.06.001. Epub 2016 Jun 4.

PMID:
27268726
8.

Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.

Youssef E, Fontanesi J, Mott M, Kraut M, Lucas D, Mekhael H, Ben-Josef E.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):514-9.

PMID:
12243830
9.

Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.

Gronchi A, Miceli R, Allard MA, Callegaro D, Le Péchoux C, Fiore M, Honoré C, Sanfilippo R, Coppola S, Stacchiotti S, Terrier P, Casali PG, Le Cesne A, Mariani L, Colombo C, Bonvalot S.

Ann Surg Oncol. 2015 May;22(5):1447-54. doi: 10.1245/s10434-014-4130-7. Epub 2014 Oct 10.

PMID:
25300609
10.

Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma.

Molina G, Hull MA, Chen YL, DeLaney TF, De Amorim Bernstein K, Choy E, Cote G, Harmon DC, Mullen JT, Haynes AB.

J Surg Oncol. 2016 Dec;114(7):814-820. doi: 10.1002/jso.24427. Epub 2016 Sep 16.

PMID:
27634478
11.
12.

A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.

Bremjit PJ, Jones RL, Chai X, Kane G, Rodler ET, Loggers ET, Pollack SM, Pillarisetty VG, Mann GN.

Ann Surg Oncol. 2014 Jul;21(7):2150-8. doi: 10.1245/s10434-014-3616-7. Epub 2014 Mar 11.

PMID:
24615180
13.

Metastasis in dedifferentiated liposarcoma: Predictors and outcome in 148 patients.

Tirumani SH, Tirumani H, Jagannathan JP, Shinagare AB, Hornick JL, Ramaiya NH, Wagner AJ.

Eur J Surg Oncol. 2015 Jul;41(7):899-904. doi: 10.1016/j.ejso.2015.01.012. Epub 2015 Jan 24.

PMID:
25659772
14.

Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.

Sriussadaporn S, Sriussadaporn S, Pak-art R, Kritayakirana K, Prichayudh S, Samorn P.

J Med Assoc Thai. 2014 Jun;97(6):598-614.

PMID:
25137877
15.

Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.

Bautista N, Su W, O'Connell TX.

Am Surg. 2000 Sep;66(9):832-6.

PMID:
10993610
16.

Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.

Trovik LH, Ovrebo K, Almquist M, Haugland HK, Rissler P, Eide J, Engellau J, Monge OR, Nyhus AB, Elde IK, Jebsen NL.

Acta Oncol. 2014 Sep;53(9):1165-72. doi: 10.3109/0284186X.2014.921723. Epub 2014 Jul 7.

PMID:
25000415
17.

Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.

Fiore M, Grosso F, Lo Vullo S, Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L, Mariani L, Casali PG, Gronchi A.

Cancer. 2007 Jun 15;109(12):2522-31.

18.

[Retroperitoneal sarcomas: diagnostic and therapy].

Gockel I, Oberholzer K, Gönner U, Mantai S, Junginger T.

Zentralbl Chir. 2006 Jun;131(3):223-9. German.

PMID:
16739063
19.

Outcome and prognosis in retroperitoneal soft tissue sarcoma.

Catton CN, O'Sullivan B, Kotwall C, Cummings B, Hao Y, Fornasier V.

Int J Radiat Oncol Biol Phys. 1994 Jul 30;29(5):1005-10.

PMID:
8083069
20.

Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis.

Ghadimi MP, Al-Zaid T, Madewell J, Peng T, Colombo C, Hoffman A, Creighton CJ, Zhang Y, Zhang A, Lazar AJ, Pollock RE, Lev D.

Ann Surg Oncol. 2011 Dec;18(13):3762-70. doi: 10.1245/s10434-011-1794-0. Epub 2011 May 26.

PMID:
21614627

Supplemental Content

Support Center